Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents - response

Michael Tsatsos^{1

2

3

4}, Cheryl MacGregor², Ioannis Athanasiadis³, Marilita M Moschos⁴, Parwez Hossain², David Anderson²

Affiliations

¹ Royal Eye Infirmary, Dorset County Hospital NHS Foundation Trust, Dorchester, UK.
² Southampton University Hospitals NHS Foundation Trust, Southampton, UK.
³ Moorfields Eye Hospital NHS Foundation Trust, London, UK.
⁴ University of Athens, Athens, Greece.

Comment

Michael Tsatsos et al. Clin Exp Ophthalmol. 2017 Apr.

. 2017 Apr;45(3):317.

doi: 10.1111/ceo.12835. Epub 2016 Oct 20.

Michael Tsatsos^{1

2

3

4}, Cheryl MacGregor², Ioannis Athanasiadis³, Marilita M Moschos⁴, Parwez Hossain², David Anderson²

¹ Royal Eye Infirmary, Dorset County Hospital NHS Foundation Trust, Dorchester, UK.
² Southampton University Hospitals NHS Foundation Trust, Southampton, UK.
³ Moorfields Eye Hospital NHS Foundation Trust, London, UK.
⁴ University of Athens, Athens, Greece.

No abstract available

Comment on

Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents - comment.
Serna-Ojeda JC, Graue-Hernandez EO. Serna-Ojeda JC, et al. Clin Exp Ophthalmol. 2017 Apr;45(3):316-317. doi: 10.1111/ceo.12834. Epub 2016 Oct 11. Clin Exp Ophthalmol. 2017. PMID: 27620850 No abstract available.